Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2025
Provided By GlobeNewswire
Last update: May 14, 2025
BOSTON and LONDON, May 14, 2025 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today reported financial results and business highlights for the first quarter ended March 31, 2025.
Read more at globenewswire.com
